Cathal Friel, Executive Chairman of Open Orphan discusses the ethics approval granted for their COVID-19 human challenge study model
Episode 137, Feb 17, 2021, 01:02 PM
Cathal Friel, Executive Chairman of Open Orphan discusses the ethics approval granted for their COVID-19 human challenge study model
Cathal Friel, Executive Chairman of Open Orphan #ORPH discusses the significance of the ethics approval granted for their COVID-19 human challenge study model.
Open Orphan is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations.